171 related articles for article (PubMed ID: 38181016)
21. Neuroendocrine carcinoma of the cervix: a systematic review of the literature.
Tempfer CB; Tischoff I; Dogan A; Hilal Z; Schultheis B; Kern P; Rezniczek GA
BMC Cancer; 2018 May; 18(1):530. PubMed ID: 29728073
[TBL] [Abstract][Full Text] [Related]
22. Patterns of recurrence and survival in neuroendocrine cervical cancer.
Stecklein SR; Jhingran A; Burzawa J; Ramalingam P; Klopp AH; Eifel PJ; Frumovitz M
Gynecol Oncol; 2016 Dec; 143(3):552-557. PubMed ID: 27645621
[TBL] [Abstract][Full Text] [Related]
23. [Value of postoperative radiotherapy and analysis of prognostic factors in early-stage neuroendocrine carcinoma of cervix].
Song XC; Zhang H; Zhong S; Tan XJ; Ma SQ; Jin Y; Pan LY; Wu M; Cao DY; Yang JX; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2023 Sep; 58(9):680-690. PubMed ID: 37724385
[No Abstract] [Full Text] [Related]
24. Development and external validation of a novel prognostic nomogram for overall survival in prostate cancer patients with bone metastatic: a retrospective study of the SEER-based and a single Chinese center.
Zhang H; Jiang X; Jiao L; Sui M
J Cancer Res Clin Oncol; 2023 Nov; 149(14):12647-12658. PubMed ID: 37450026
[TBL] [Abstract][Full Text] [Related]
25. Nomogram predicting overall survival of rectal squamous cell carcinomas patients based on the SEER database: A population-based STROBE cohort study.
Diao JD; Wu CJ; Cui HX; Bu MW; Yue D; Wang X; Liu YL; Yang YJ
Medicine (Baltimore); 2019 Nov; 98(46):e17916. PubMed ID: 31725640
[TBL] [Abstract][Full Text] [Related]
26. [Development and Evaluation of Prognostic Nomogram Model for Adult Ventricle Glioma Patients].
Zhang HD; Niu XD; Zhou XW; Yang Y; Li JM; Gan YJ; Wang X; Liu YH; Mao Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jul; 53(4):588-596. PubMed ID: 35871728
[TBL] [Abstract][Full Text] [Related]
27. Prognostic nomogram for primary splenic lymphoma: a SEER database-based study.
Chen F; Long H; Ding J; Ren J; Qu B; Cao P; Wang Z; Wu Z; Ma Q; Ma Z
Am J Cancer Res; 2023; 13(12):5825-5845. PubMed ID: 38187057
[TBL] [Abstract][Full Text] [Related]
28. Construction and validation of a novel prognostic nomogram for predicting overall survival in lung adenocarcinoma patients with different patterns of metastasis.
Xiong Y; Gu F; Cui J; Liu Y; Sun M; Gu X; Zhong L; Zhang K; Liu L
J Cancer Res Clin Oncol; 2023 Nov; 149(16):15039-15053. PubMed ID: 37612389
[TBL] [Abstract][Full Text] [Related]
29. A novel nomogram and risk stratification system predicting the cancer-specific survival of patients with gastric neuroendocrine carcinoma: a study based on SEER database and external validation.
Song X; Xie Y; Lou Y
BMC Gastroenterol; 2023 Jul; 23(1):238. PubMed ID: 37452300
[TBL] [Abstract][Full Text] [Related]
30. Development and validation of a dynamic survival nomogram for metastatic non-small cell lung cancer based on the SEER database and an external validation cohort.
Wang Q; Wang Y; Wang X; Nakamura Y; Hydbring P; Yamauchi Y; Zhao X; Cao M
Transl Lung Cancer Res; 2022 Aug; 11(8):1678-1691. PubMed ID: 36090634
[TBL] [Abstract][Full Text] [Related]
31. Development and validation of a nomogram to predict the prognosis of patients with gastric cardia cancer.
Shi X; Xu L; Ma B; Wang S
Sci Rep; 2020 Aug; 10(1):14143. PubMed ID: 32839498
[TBL] [Abstract][Full Text] [Related]
32. Establishment and validation of a prognostic nomogram for patients with colorectal neuroendocrine carcinoma.
Zhuang Y; Yu H; Chen CJ; Jian JL; Wu XY
Asian J Surg; 2024 Jan; 47(1):433-442. PubMed ID: 37778975
[TBL] [Abstract][Full Text] [Related]
33. Development and validation of prognostic nomograms for early-onset colon cancer in different tumor locations: a population-based study.
Zhu S; Tu J; Pei W; Zheng Z; Bi J; Feng Q
BMC Gastroenterol; 2023 Oct; 23(1):362. PubMed ID: 37865754
[TBL] [Abstract][Full Text] [Related]
34. Prognostic nomogram for glioblastoma (GBM) patients presenting with distant extension: a seer-based study.
Zhou Z; Yuan J; Chen H; Zhan LP; Sun EY; Chen B
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11595-11605. PubMed ID: 37401940
[TBL] [Abstract][Full Text] [Related]
35. Development and validation of a prognostic nomogram for early stage non-small cell lung cancer: a study based on the SEER database and a Chinese cohort.
Zhou L; Zhang Y; Chen W; Niu N; Zhao J; Qi W; Xu Y
BMC Cancer; 2022 Sep; 22(1):980. PubMed ID: 36104656
[TBL] [Abstract][Full Text] [Related]
36. Prognostic nomogram predicts overall survival in pulmonary large cell neuroendocrine carcinoma.
He Y; Liu H; Wang S; Chen Y
PLoS One; 2019; 14(9):e0223275. PubMed ID: 31560723
[TBL] [Abstract][Full Text] [Related]
37. A Web-Based Prognostic Model for Pediatric Genitourinary Rhabdomyosarcoma: Analysis of Population-Based Cohort With External Validation.
Li J; Huang Y; Li Y; Liu P; Cheng H; Song H; Sun N; Shamil MA; Zhang W
Front Public Health; 2022; 10():870187. PubMed ID: 35619827
[TBL] [Abstract][Full Text] [Related]
38. Construction and validation of prognostic nomogram and clinical characteristics for ovarian endometrioid carcinoma: an SEER-based cohort study.
Ye W; Wang Q; Lu Y
J Cancer Res Clin Oncol; 2023 Nov; 149(15):13607-13618. PubMed ID: 37515614
[TBL] [Abstract][Full Text] [Related]
39. A Prognostic Nomogram for Predicting Overall Survival in Patients With Small-Cell Carcinoma of the Uterine Cervix: A SEER Population-Based Study.
Chen Y; Chen J; Lin X; Zheng J; Li S; Zheng X
Technol Cancer Res Treat; 2022; 21():15330338221110673. PubMed ID: 35929137
[No Abstract] [Full Text] [Related]
40. Personalized prognostic prediction tool for high-grade neuroendocrine cervical cancer: a SEER database analysis and single-center validation.
Chen X; Shi W; Wang C; Zhu H
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17395-17404. PubMed ID: 37853082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
